Longevity Acquisition Corp

Longevity Acquisition Corp (Nasdaq: LOAC) is a blank-check company that completed its initial public offering in 2020, targeting acquisition opportunities in the healthcare and longevity sector, which encompasses biotechnology, medical devices, diagnostics, and health-focused technology businesses. The SPAC filed an 8-K current report with the SEC on March 18, 2021, under accession number 0001104659-21-038087, disclosing a material event consistent with the company's ongoing search for a qualifying business combination. LOAC is sponsored by Longevity Sponsor LLC and was formed to leverage sector expertise in identifying life-science and longevity-oriented targets. For full filing history, sponsor details, and deal-status tracking on LOAC, sign up for complete data access at SpacDesk.